Advertisement

Adult Patient with Resistant Hypertension Secondary to Comorbidities

  • Massimo Salvetti
Chapter
Part of the Practical Case Studies in Hypertension Management book series (PCSHM)

Abstract

This clinical case describes the workup and the subsequent treatment changes in a patient referred for resistant hypertension to a Blood Pressure Clinic. Lifestyle was certainly not optimal in this obese patient. Obesity and overweight are quite common in patients with BP elevation, being present in about 75 % of the hypertensive patients seen by general practitioners or specialists. Together with combination treatment with antihypertensive drugs, lifestyle changes represent the most effective strategy for reaching BP control in this group of patients, in whom limitation (and, if possible, complete cessation) of alcohol intake, limitation of dietary salt and increase in physical activity are particularly effective in reducing blood pressure values. When target blood pressure is not reached despite the aforementioned measures, after exclusion of sleep apnoea (which may significantly contribute to treatment resistance), mineralocorticoid receptor antagonists may be considered as third-line drugs in these patients, due to the possible role of increased aldosterone levels in the pathogenesis of resistance to treatment.

Keywords

Ambulatory Blood Pressure Monitoring Resistant Hypertension Normal Heart Rate Home Blood Pressure Mineralocorticoid Receptor Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.CrossRefPubMedGoogle Scholar
  2. 2.
    Reboldi G, Angeli F, Verdecchia P. Ambulatory blood interpretation of pressure profile for risk stratification. Keep it simple. Hypertension. 2014;63:913–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Calhoun D, Booth J, Oparil S, Irvin M, Shimbo D, Lackland D, Howard G, Safford M, Muntner P. Refractory hypertension determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension. 2014;63:451–8.CrossRefPubMedGoogle Scholar
  4. 4.
    De la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898–902.CrossRefPubMedGoogle Scholar
  5. 5.
    Muiesan ML, Salvetti M, Rizzoni D, Paini A, Agabiti-Rosei C, Aggiusti C, Agabiti RE. Resistant hypertension and target organ damage. Hypertens Res. 2013;36(6):485–91.CrossRefPubMedGoogle Scholar
  6. 6.
    Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H, et al. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens. 2004;17:904–10.CrossRefPubMedGoogle Scholar
  7. 7.
    Rojas E, Velasco M, Bermúdez V, Israili Z, Bolli P. Targeting hypertension in patients with cardiorenal metabolic syndrome. Curr Hypertens Rep. 2012;14(5):397–402.CrossRefPubMedGoogle Scholar
  8. 8.
    Jordan J, Schlaich M, Redon J, Narkiewicz K, Luft FC, Grassi G, Dixon J, Lambert G, Engeli S, for the European Society of Hypertension Working Group on Obesity and the Australian and New Zealand Obesity Society. European society of hypertension working group on obesity: obesity drugs and cardiovascular outcomes. J Hypertens. 2011;29:189–93.CrossRefPubMedGoogle Scholar
  9. 9.
    Malacco E, Omboni S, Volpe M, Auteri A, Zanchetti A, ESPORT Study Group. Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study. J Hypertens. 2010;28(11):2342–50.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Massimo Salvetti
    • 1
  1. 1.ASST Spedali Civili di BresciaClinica Medica-University of BresciaBresciaItaly

Personalised recommendations